Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Diagnostics (Basel, Switzerland)|May 28, 2022
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene PanelDeborah Malvi, Francesco Vasuri, Thais Maloberti, et al.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
Journal of Neuro-Oncology|March 8, 2024
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective studyVincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, et al.
The Oncologist|September 30, 2018
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent GlioblastomaAlba A Brandes, Miguel Gil-Gil, Frank Saran, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Diagnostics (Basel, Switzerland)|May 28, 2022
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene PanelDeborah Malvi, Francesco Vasuri, Thais Maloberti, et al.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
Journal of Neuro-Oncology|March 8, 2024
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective studyVincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, et al.
The Oncologist|September 30, 2018
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent GlioblastomaAlba A Brandes, Miguel Gil-Gil, Frank Saran, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Pageof 17